跳至主要内容
临床试验/NCT01405183
NCT01405183已完成不适用

Association Between Hepatitis C Infection and Renal Cell Carcinoma, a Case Control Study

Henry Ford Health System1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
240
试验地点
1
主要终点
Prevalence of hepatitis C in renal cell carcinoma patients

研究概览

简要总结

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months.
  • Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months

排除标准

  • Patients who are unwilling to provide consent
  • Patients who decline to complete a questionnaire
  • Patient in who blood sample cannot be obtained
  • Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

结局指标

主要结局

Prevalence of hepatitis C in renal cell carcinoma patients

时间窗: 2 years

Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Humberto C. Gonzalez

MD

Henry Ford Health System

研究点 (1)

Loading locations...

相似试验